NextGxDx Inc., the comprehensive online marketplace for
genetic testing, recently announced its partnership with
) to deliver an integrated platform that will help clinicians to
improve genetic test ordering. The new clinical interface for
genetic testing will add to athenahealth's existing suite of
ATHENAHEALTH IN (ATHN): Free Stock Analysis
BG MEDICINE INC (BGMD): Free Stock Analysis
CANCER GENETICS (CGIX): Get Free Report
STREAMLINE HLTH (STRM): Free Stock Analysis
To read this article on Zacks.com click here.
athenahealth is one of the leading provider of cloud-based
services for electronic health record (EHR), practice management,
and care coordination. The collaboration of the two companies
will enable ATHN's clinicians to avail genetic testing through an
integrated EHR platform.
NextGxDx believes that all the underlying challenges in the
healthcare industry can be overcome through the adoption of
superior technology. Genetic testing is one such area where
state-of-the-art technology can improve efficiency, while
reducing the complexities encountered in the diagnostic process.
However, despite its popularity and increasing applicability to
patient outcomes, genetic order testing remains underutilized due
to its growth rate.
NextGxDx online tool, acts as a one stop shop to allow easier
search, comparison and ordering of genetic tests. The online
platform is linked with an intuitive user interface, thereby
enabling physicians and other health care professionals to access
the current date listings of all genetic tests from CLIA
certified laboratories, order tests online, and receive results
electronically. Additionally, the bioinformatics team of the
company utilizes proprietary tools to update and organize test
The single window network of NextGxDx offers clinicians a broad
spectrum to order testing from, as it showcases NextGxDx
affiliated labs within athenaClinicals, athenahealth's Best in
KLAS EHR service, thus streamlining the genetic testing workflow.
Recently NextGxDx formed an alliance to add Cancer Genetics Inc.
(CGIX), Inc. to Genetic Testing Platform. It was seen that Cancer
Genetics, had a catalog of more than 100 regulatory approved
oncology testing products and solutions for easy search,
comparison and ordering. Moreover, genetic testing within
oncology holds immense future potential as cancer-testing is
emerging as a rapidly growing market worldwide.
Currently, ATHN carries a Zacks Rank #5 (Sell). Other medical
information systems stocks that are worth a look include
Streamline Health Solutions, Inc.
), with a Zacks Rank #2 (Buy) and medical services stocks that
can be considered include
BG Medicine, Inc.
Cancer Genetics, Inc
) with a Zacks Rank #2 (Buy).